LYMPHATIC DRAINAGE IN THE BREAST BEFORE AND UP TO FIVE YEARS AFTER A REDUCTION MAMMAPLASTY
|
|
- Maryann Delphia Gray
- 5 years ago
- Views:
Transcription
1 157 Lymphology 49 (2016) LYMPHATIC DRAINAGE IN THE BREAST BEFORE AND UP TO FIVE YEARS AFTER A REDUCTION MAMMAPLASTY L. Zetterlund, R. Axelsson, L. Svensson, L. Perbeck, F. Celebioglu Department of Surgery (LZ,FC), Stockholm South General Hospital, Department of Clinical Science and Education; Department of Radiology (RA), and Department of Medical Physics (LS), Karolinska University Hospital Huddinge, Department of Clinical Science, Intervention and Technology (CLINTEC); and Department of Breast and Endocrine Surgery (LP), Karolinska University Hospital Solna, and Department of Molecular Medicine and Surgery, Karolinska Institutet, Sweden ABSTRACT The aim of this study was to investigate lymph circulation before and after breast reduction mammaplasty in different parts of the breast and with two different carriers of the radiopharmaceutical. Nine patients with breast hypertrophy planned for bilateral breast reduction mammaplasty were prospectively included in the study. The breast operation procedure was decided on intraoperatively. The regional lymph circulation in the breast was measured preoperatively by Technetium ( 99m Tc) clearance in 4 different locations in each breast 1, 2 and 3 hours after injection. The procedure was repeated at one month and in six of the nine women also five years postoperatively with injection sites chosen to correspond to the preoperative location of that breast pedicle. Two different types of carriers of the radiopharmaceutical were tested, dextran in the right and nanocoll in the left breast. Dextran had a much more rapid clearance than nanocoll. There was no significant regional difference in lymph drainage up to five years after the mammaplasty, independent of dextran or nanocoll as being the carrier of the radiopharmaceutical. Keywords: lymphatic drainage, lymphoscintigraphy, lymphatic imaging, radiopharmaceutical, breast hypertrophy, reduction mammaplasty Lymphedema after breast cancer surgery and axillary lymph node dissection is relatively common at 6-30% (1) and in combination with irradiation, the risk increases even further (2). Sentinel lymph node biopsy is an accurate predictor of axillary lymph node status in patients with early breast cancer (3,4) and is associated with a significantly lower risk of arm morbidity compared to axillary lymph node dissection including arm lymphedema (1). Anatomical mapping studies have shown how lymph nodes and lymph vessels are organized but not much is known about lymph flow dynamics and how it is affected after previous breast surgery. Often reconstructive surgery is performed on the contralateral breast after breast cancer surgery to achieve symmetry. The risk of developing a contralateral breast cancer persists for at least 20 years after treatment for early-stage breast cancer and the annual risk is approximately 0.75% per year (5). Reduction mammaplasty implies that breast glandular tissue and skin is removed and the nipple areola complex is raised to a new position by use of different kind of pedicles. Theoretically, the lymph circulation in the
2 158 Fig. 1. Preoperatively chosen regions in the breasts for administration of the radiopharmaceutical. Regions 1-4 in the right breast received dextran-linked radiopharmaceutical and regions 5-8 in the left breast received nanocolllinked radiopharmaceutical. breast might be altered, possibly influencing both spread of tumor cells and reliability of the sentinel lymph node biopsy technique for staging of axillary lymph nodes. Disruption of breast lymphatics might modify drainage pathways, and performance of a sentinel lymph node biopsy after a previous excisional biopsy is still controversial (4,6-8). The aim of the present study was to investigate lymphatic drainage from different regions of reduction mammaplasty operated breasts, particularly focusing on drainage from the pedicle inside the breast. A secondary aim was to test two different types of carriers of the radiopharmaceutical. MATERIALS AND METHODS Patients Women with breast hypertrophy planned for bilateral reduction mammaplasty at Karolinska University Hospital Huddinge were prospectively included in the study between January and December The regional lymph circulation in the breasts was measured preoperatively and one month postoperatively. Six of the nine patients were also measured five years postoperatively. Scintigraphic images are missing of the syringes 1 month postoperatively for one patient and images acquisitioned 3 hours after injection preoperatively for another patient. Breast Operation Procedures Reduction mammaplasty implies a reduction of breast glandular tissue and skin and raising of the nipple areola complex based on different types of pedicles. The decision whether to use a medially or a vertically based pedicle was made intraoperatively when the skin over the pedicle had been deepithelialized and depended on the possibility to move the nipple-areola complex to its new position without tension in the tissues. In the medially based pedicle, breast glandular tissue was extirpated caudally in the breast and cranially at the new location for the nipple. The pedicle was turned cranially like a U into the new location for the nipple areola complex. In the vertically based pedicle, breast tissue was removed medially and laterally from the pedicle.
3 159 Fig. 2. Postoperatively chosen regions in the breasts for administration of the radiopharmaceutical. Regions 1-4 in the right breast received dextran-linked radiopharmaceutical and regions 5-8 in the left breast received nanocolllinked radiopharmaceutical. The deepithelialized pedicle was covered by the skin and subcutaneous tissue of the flaps. Administration of Radiotracer Preoperatively, injection site numbers 1 and 5 were chosen two cm above the planned border of the areola, injection site numbers 2 and 6 were two cm lateral to the planned vertical incision line and two cm above the submammary fold, injection site numbers 3 and 7 were two cm medial to the planned vertical incision line and two cm above the submammary fold and injection site numbers 4 and 8 were two cm from the planned postoperative lower border of the areola and two cm medial to the vertical incision line. The injections were given five mm deep into the subcutaneous fat (Fig. 1). Postoperatively, injection sites were chosen to correspond to the same region that had been injected preoperatively and the injections were given at the same depth, except in the medial pedicle, which postoperatively was located deeper. In these regions (4 and 8, respectively), the injections were given two cm deep into the subcutaneous tissue of the pedicle. The medially based pedicle was postoperatively located caudally from the border of the areola as were the injection sites of the vertically based pedicle (Fig. 2). Each patient was injected with 5 MBq 99m Tc-dextran in 0.1 ml in each of four locations in the right breast and with 5 MBq 99m Tc-nanocoll in 0.1 ml in the corresponding four locations in the left breast. The syringes were imaged with the same gamma camera as the study patients before and after each injection to assess the amount of injected activity. 99m Tc-Dextran 99m Tc-dextran was prepared according to a standard stannous reduction method using preparations of dextran and stannous chloride. Before each study, radiotracer was obtained by adding freshly eluted 99m Tcpertechnetate. The reagent kits were prepared in 15 unit batches, dextran (Mw 64,000-76,000) in a concentration of 50 mg/ml and Sncl 2 2H 2 0 in a concentration of 1 mg/ml. The reagent solutions were prepared under aseptic conditions, dispensed in 1 ml portions through a 0.22 µm sterile membrane filter into 10 ml sterile vials which were stoppered and stored at -15 C until used.
4 160 Lymphoscintigraphy was performed preoperatively and twice postoperatively, after one month and five years after the breast reduction mammaplasty. Each patient was injected in the right breast with a dextranand in the left breast with a nanocoll-labeled radiopharmaceutical on four corresponding locations in each breast defined by the breast surgeon. Labeling 0.5 ml of stannous chloride solution (1mg/ml) was added to the vial containing 1 ml of dextran 50 mg/ml. 1ml 99m Tcpertechnetate solution with a radioactive concentration of 120 MBq/ml was added to the dextran/sn reagent solution, which was mixed and incubated for five minutes. The solution was diluted with 3.5 ml of 0.9% NaCl to a final radioactive concentration of 20 MBq/ml. Quality Control The labeling efficiency was measured by thin layer chromatography using ITLC-SG strips (Pall) with acetone as mobile phase. The strips were scanned in gamma camera. R f 99m Tc-dextran=0, R f 99m TcO4 - = m TcO4 - was found to be less than 2% in every case. 99m Tc-Nanocoll 99m Tc-nanocoll (Nanocoll, GE Healthcare): 1 ml 99m Tc-pertechnetate solution with a radioactive concentration of 120 MBq/ml was added to the nanocoll kit. Then 5 ml of 0.9% NaCl solution was added to obtain the same final radioactive concentration as the 99m Tc-dextran solution (20 MBq/ml). Imaging Procedures Imaging was performed with a Siemens ECAM gamma camera equipped with a low-energy, high-resolution, parallel holecollimator. Data acquisition was performed in anterior projections with the patient supine and the gamma camera centered over the areola regions. A dynamic acquisition was started directly after injection and lasted for 30 minutes (10 frames per minute). Planar images were acquired 1 hour, 2 hours, and 3 hours after injection with an acquisition time of 10 minutes. Evaluation of Scintigraphic Data Regions of interest (ROI) were drawn around each of the eight injection sites (four on the left and four on the right side). Counts registered in each ROI on the scintigraphic images were converted to percentage of injected dose and corrected for physical decay of 99m Tc. The elimination of radiotracer from the injection sites (wash-out) was considered a measure of lymph drainage. The study was approved by the Regional Ethical Review Board (Dnr 410/02) and the Regional Nuclear Protection Committeé (Dnr 18/02) in Statistical Analysis The statistical analysis was performed with the Statistica statistical software package (Statistica 10, StatSoft Inc, Tulsa, OK, USA). The data were analyzed by nonparametric one-way-analysis of variance. P values less than 0.05 were considered significant. The class 1 interclass correlation test (ICC) was used (9,10). This is a typical test to measure the agreement between two data sets with 1.0 indicating perfect agreement. According to Landis and Koch, values greater than 0.81 indicate almost perfect agreement (11). RESULTS Patients Nine women planned for breast reduction mammaplasty were prospectively included during the study period. In four of
5 161 TABLE 1 Clinical Characteristics of the Patients compared to postoperatively. However, the postoperative clearance from region 5 was not significantly slower compared to the other regions in the same breast. In the three other regions (region 6-8) in the left breast, there was no significant difference in clearance between regions or visits (Fig. 3) DISCUSSION the women the breast surgeon intraoperatively decided on a medially based nipple areola pedicle according to the technique of Strömbeck (12). Five women received a vertically/caudally based pedicle, McKissock or Robins technique (13,14). Clinical characteristics of the patients are given in Table 1. Lymph Drainage Evaluations of the scintigraphic data were performed by one nuclear radiologist and one breast surgeon, who achieved an interclass correlation (ICC) in their measurements of at least 94.5%. The difference is not statistically significant meaning that the method is stable and independent of examiner. Dextran, carrier of the tracer in the right breast, had a much quicker clearance (washout) compared to nanocoll in the left breast, especially preoperatively. Clearance of the radiotracer from all regions in the right breast (dextran) was faster preoperatively compared to postoperatively. The slowest elimination was seen five years postoperatively (p-value = ). There was no significant difference in clearance between the different regions in the right breast. On the left side where nanocoll was carrier of the radiopharmaceutical, the injection site above the areola (region 5) displayed a significantly (p-value=0.03) slower clearance of radiotracer preoperatively The present study investigated regional lymph flow dynamics in nine prospectively recruited women before and after bilateral reduction mammaplasty which took place between January and December Six of the nine women were also examined in 2010, just over five years after the mammaplasty. We used two different types of carriers of the radiopharmaceutical, dextran in the right breast and nanocoll in the left breast. In the right breast, the clearance was significantly quicker preoperatively compared to postoperatively, and the slowest clearance was observed five years postoperatively. Dextran was eliminated quicker than nanocoll, especially preoperatively. This we concluded must be due to the smaller particle size of dextran. No significant regional difference in clearance was seen in the right breast, neither pre- nor postoperatively. The particle size of dextran was small enough to allow equal lymph flow independent of breast region and amount of lymph vessel disruption and scarring. The reason why the clearance was quicker one month postoperatively compared to five years postoperatively could be due to increased lymph flow following the acute inflammatory reaction. In an earlier publication in Lymphology, Perbeck et al reported on long-term increase in lymph flow in the breast, 1.5-fold in a breast operated for a benign lesion, 2.5-fold in the contralateral non-operated, but indirectly irradiated breast and 4-fold in the operated, irradiated breast 2-5 years after surgery. None of these breasts demonstrated any clinical lymphedema (15). In the left breast, elimination of nanocolloid did not differ significantly temporally
6 162 Fig. 3. Clearance of the radiopharmaceutical from different regions of interest (ROI) in the right and left breast. ROI 1-4: Right breast (dextran-linked radiopharmaceutical) and ROI 5-8: Left breast (nanocoll-linked radiopharmaceutical). Visit 1= preoperatively; Visit 2= one month postoperatively; Visit 3= five years postoperatively. The y-axis depicts counts registered in each region 1 (blue), 2 (red) and 3 (green) hours after injection. The counts were converted to percentage of injected dose and corrected for physical decay of 99m Tc. or between regions except for region 5 above the nipple areola complex where the elimination unexpectedly was significantly slower preoperatively compared to postoperatively. The authors have no reasonable explanation for this finding. As mentioned above, the behavior of the carrier is dependent on the particle size. In the localization of sentinel lymph nodes, smaller particles travel more quickly and reach more lymph nodes, thereby offering lower false-negative rates (8) with the risk of only a fraction of the radiotracer being retained in the first lymph node. On the contrary, large particles are trapped in the interstitium and can be retained for a long time at the injection site (16). In Europe, nanocolloid with a particle size of <16 nm and 95% linked to 99m Technetium, is the most frequently used radiopharmaceutical for lymphoscintigraphy (17). A particle size ranging from 100 to 200 nm is considered ideal for retention in the sentinel lymph node (16). The relatively larger particle size of nanocoll was retained equally pre- as postoperatively except for in region 5. Images acquired 3 hours, in comparison with 1 hour after injection, did not change the clearance significantly. Limitations with this study are that only
7 163 nine women were included and that different kinds of reduction mammaplasty techniques were used. The type of pedicle to be used was decided upon intraoperatively. The purpose was to move the nipple areola complex to its new position without tension. Four patients had a medially based pedicle, but five had a vertically or caudally based pedicle in which the preoperative injection sites in position 4 and 8 were not the same as the postoperative sites. The preoperative injection site should theoretically have been at the six o clock position and two centimeters below the areola border. However, these were preoperative measuring areas and the likelihood that there should be a difference between these areas below and medially from the nipple areola complex is very low, which is also supported by our results showing no regional difference in clearance of the radiopharmaceutical postoperatively. According to Mostbeck et al and also Partsch et al, assessment of abnormal lymphatic drainage cannot be done only by measuring clearance rates of the radiotracer but should also include a standardized stress test, assessment of both prefascial and subfascial lymph transport as well as quantification of storage rates over the regional lymph nodes (18,19). In this study, our aim was to evaluate regional differences in lymph circulation from different parts of the breast before and after a reduction mammaplasty. Measurement of axillary or regional lymph nodal storage of the radiopharmaceutical was not performed. The reason for this is that this information would not have added any knowledge about regional lymph flow differences, instead it would have been a measure of the total lymph clearance from the breast. The strengths of this study are that six of the women were examined as long as five years postoperatively and that the results add information about lymph flow dynamics after breast surgery and how it is affected regionally and temporally. If these results, which suggest that the regional lymph clearance is not affected significantly after prior breast surgery, can be reproduced in larger studies, a sentinel lymph node biopsy after earlier breast surgery should be considered feasible. CONCLUSIONS This study showed that the lymph drainage from different areas and pedicles in the breast after a reduction mammaplasty is not altered significantly regionally, measured as the elimination of 99m Tcnanocoll or 99m Tc-dextran up to five years postoperatively. The two different carriers of the radiopharmaceutical demonstrate different lymph drainage timing with elimination of 99m Tc-dextran occurring much faster due to its smaller particle size. ACKNOWLEDGMENTS Thank you to all involved staff at the Department of Nuclear Medicine, Karolinska University Hospital, Huddinge, Sweden for their assistance. REFERENCES 1. Petrek, JA, MC Heelan: Incidence of breast carcinoma-related lymphedema. Cancer 83 (1998), Swedborg, I, A Wallgren: The effect of preand postmastectomy radiotherapy on the degree of edema, shoulder-joint mobility, and gripping force. Cancer 47 (1981), Krag, DN, SJ Anderson, TB Julian, et al: Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: Overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 11 (2010), Krag, D, D Weaver, T Ashikaga, et al: The sentinel node in breast cancer a multicenter validation study. NEJM 339 (1998), Hill-Kayser, CE, EE Harris, WT Hwang, et al: Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation. Inter. J. Rad. Oncol. Bio. Phys. 66 (2006), Borgstein, PJ, R Pijpers, EF Comans, et al: Sentinel lymph node biopsy in breast cancer:
8 164 Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J. Am. Col. Surg. 186 (1998), Estourgie, SH, RA Valdes Olmos, OE Nieweg, et al: Excision biopsy of breast lesions changes the pattern of lymphatic drainage. Brit. J. Surg. 94 (2007), Wong, SL, MJ Edwards, C Chao, et al: The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Ann. Surg. Oncol. 9 (2002), Bartko, JJ: The intraclass correlation coefficient as a measure of reliability. Psych. Rep. 19 (1966), Shrout, PE, LJ Fleiss: Intraclass correlations: Uses in assessing rater reliability. Psych. Bull. 86 (1979), Landis, JR, GG Koch: The measurement of observer agreement for categorical data. Biometrics. 33 (1977), Strombeck, JO: Mammaplasty: Report of a new technique based on the two-pedicle procedure. Brit. J. Plas. Surg. 13 (1960), McKissock, PK: Reduction mammaplasty with a vertical dermal flap. Plast. Recon. Surg. 49 (1972), Robbins, TH: A reduction mammaplasty with the areola-nipple based on an inferior dermal pedicle. Plas. Recon. Surg. 59 (1977), Perbeck, L, F Celebioglu, L Svensson, et al: Lymph circulation in the breast after radiotherapy and breast conservation. Lymphology. 39 (2006), Yararbas, U, AM Argon, L Yeniay, et al: The effect of radiocolloid preference on major parameters in sentinel lymph node biopsy practice in breast cancer. Nuc. Med. Bio. 37 (2010), Jimenez, IR, M Roca, E Vega, et al: Particle sizes of colloids to be used in sentinel lymph node radiolocalization. Nuc. Med. Comm. 29 (2008), Mostbeck, A, H Partsch: [Isotope lymphography possibilities and limits in evaluation of lymph transport]. Wien. Med. Wochenschr. 149 (1999), Partsch, H: Assessment of abnormal lymph drainage for the diagnosis of lymphedema by isotopic lymphangiography and by indirect lymphography. Clin. Dermatol. 13 (1995), Linda Zetterlund, MD Department of Surgery Stockholm South General Hospital SE Stockholm, Sweden Phone: Fax: linda.holmstrand-zetterlund@sll.se
ENHANCED SENTINEL LYMPHOSCINTIGRAPHIC MAPPING IN BREAST TUMOR USING THE GRADED SHIELD TECHNIQUE
ENHANCED SENTINEL LYMPHOSCINTIGRAPHIC MAPPING IN BREAST TUMOR USING THE GRADED SHIELD TECHNIQUE Yu-Wen Chen, Yung-Chang Lai, Chien-Chin Hsu, and Ming-Feng Hou 1 Departments of Nuclear Medicine and 1 Gastroenteric
More informationAustin Radiological Association Nuclear Medicine Procedure LYMPHOSCINTIGRAPHY (Tc-99m-Sulfur Colloid [Filtered])
Austin Radiological Association Nuclear Medicine Procedure LYMPHOSCINTIGRAPHY (Tc-99m-Sulfur Colloid [Filtered]) Overview Indications The Lymphoscintigraphy Study demonstrates the flow of lymph from the
More informationLYMPHOSCINTIGRAPHY: WHY DO IT?
OVERVIEW Lymphoscintigraphy refers to the scintigraphic visualization of lymphatic drainage of a specific body site following intradermal injection of a radiolabeled colloid. It is a valuable procedure
More informationIs Sentinel Node Biopsy Practical?
Breast Cancer Is Sentinel Node Biopsy Practical? Benefits and Limitations JMAJ 45(10): 444 448, 2002 Shigeru IMOTO *1, Satoshi EBIHARA *2 and Noriyuki MORIYAMA *3 *1 Breast Surgery Division, National Cancer
More informationSentinel Lymph Node Biopsy for Breast Cancer
Sentinel Lymph Node Biopsy for Breast Cancer Registrar Tutorial Adam Cichowitz Surgical Registrar The Royal Melbourne Hospital Sentinel Lymph Node Biopsy Axillary LN status important prognostic factor
More informationLymphoscintigraphy is a special type of nuclear medicine imaging that provides pictures called scintigrams of the lymphatic system.
Scan for mobile link. Lymphoscintigraphy Lymphoscintigraphy helps evaluate your body s lymphatic system for disease using small amounts of radioactive materials called radiotracers that are typically injected
More informationAdvances in Localized Breast Cancer
Advances in Localized Breast Cancer Melissa Camp, MD, MPH and Fariba Asrari, MD June 18, 2018 Moderated by Elissa Bantug 1 Advances in Surgery for Breast Cancer Melissa Camp, MD June 18, 2018 2 Historical
More informationGOSTT General concept
GOSTT General concept Francesco GIAMMARILE «Aut tace aut loquere meliora silentio» Presentation Outline Introduction: GOSTT and radioguided surgery The Sentinel Node Concept Latest technological knowledge
More informationBreast conservation surgery and sentinal node biopsy: Dr R Botha Moderator: Dr E Osman
Breast conservation surgery and sentinal node biopsy: Dr R Botha Moderator: Dr E Osman Breast anatomy: Breast conserving surgery: The aim of wide local excision is to remove all invasive and in situ
More informationRadionuclide detection of sentinel lymph node
Radionuclide detection of sentinel lymph node Sophia I. Koukouraki Assoc. Professor Department of Nuclear Medicine Medicine School, University of Crete 1 BACKGROUND The prognosis of malignant disease is
More informationThe Concept of GOSTT
IAEA Regional Training Course on Sentinel Lymph Node Mapping and Radioguided Surgery The Concept of GOSTT Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa,
More informationSentinel Node Localisation of Melanoma
Sentinel Node Localisation of Melanoma V Bongers, Diakonessenhuis, Utrecht 1. Introduction A melanoma is mostly a malignancy of the skin. The sentinel lymph node (SLN) concept of sequential progression
More informationNorthumbria Healthcare NHS Foundation Trust. Breast Sentinel Lymph Node Biopsy. Issued by the Breast Team
Northumbria Healthcare NHS Foundation Trust Breast Sentinel Lymph Node Biopsy Issued by the Breast Team Why do my Lymph Nodes require investigation? The lymphatic system is a pathway of lymph vessels and
More informationAdvances in Breast Surgery. Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015
Advances in Breast Surgery Catherine Campo, D.O. Breast Surgeon Meridian Health System April 17, 2015 Objectives Understand the surgical treatment of breast cancer Be able to determine when a lumpectomy
More informationSPECT/CT Imaging of the Sentinel Lymph Node
IAEA Regional Training Course on Hybrid Imaging SPECT/CT Imaging of the Sentinel Lymph Node Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy Vilnius,
More informationBREAST CANCER SURGERY. Dr. John H. Donohue
Dr. John H. Donohue HISTORY References to breast surgery in ancient Egypt (ca 3000 BCE) Mastectomy described in numerous medieval texts Petit formulated organized approach in 18 th Century Improvements
More informationCase 1: 79 yr-old woman with a lump in upper outer quadrant of left breast.
Case 1: 79 yr-old woman with a lump in upper outer quadrant of left breast. Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Relevant history 79-yr
More informationBreast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate surgical options
A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Breast cancer reconstruction surgery (immediate and delayed) across Ontario: Patient indications and appropriate
More informationThe Role of Sentinel Lymph Node Biopsy and Axillary Dissection
The Role of Sentinel Lymph Node Biopsy and Axillary Dissection Henry Mark Kuerer, MD, PhD, FACS Department of Surgical Oncology University of Texas MD Anderson Cancer Center SLN Biopsy Revolutionized surgical
More informationPractice of Axilla Surgery
Summer School of Breast Disease 2016 Practice of Axilla Surgery Axillary Lymph Node Dissection & Sentinel Lymph Node Biopsy 연세의대외과 박세호 Contents Anatomy of the axilla Axillary lymph node dissection (ALND)
More informationLymphoseek (technetium Tc 99m tilmanocept) Injection
Lymphoseek (technetium Tc 99m tilmanocept) Injection A Novel Receptor-Targeted Lymphatic Mapping Agent Karen B. Randall, B.S., CNMT Navidea Biopharmaceuticals Medical Science Liaison Lymphoseek (technetium
More informationThe Need for Skin Pen Marking for Sentinel Lymph Node Biopsy: A Comparative Study
Downloaded from http://journals.tums.ac.ir/ on Tuesday, August 14, 01 The Need for Skin Pen Marking for Sentinel Lymph Node Biopsy: A Comparative Study Ramin Sadeghi, MD 1 ; Mohammad Naser Forghani, MD
More informationCLAUDIU PEŞTEAN 1,2, ELENA BĂRBUŞ 1,2, ANDRA PICIU 3,4, MARIA IULIA LARG 1,2, ALEXANDRINA SABO 1,5, CRISTINA MOISESCU-GOIA 1,5, DOINA PICIU 6,7
Oncology DOI: 10.15386/cjmed-637 SENTINEL LYMPH NODE SCINTIGRAPHY IN CUTANEOUS MELANOMA USING A PLANAR CALIBRATION PHANTOM FILLED WITH TC-99M PERTECHNETATE SOLUTION FOR BODY CONTOURING CLAUDIU PEŞTEAN
More informationCorrespondence should be addressed to Donald R. Lannin;
Hindawi Surgery Research and Practice Volume 2017, Article ID 5924802, 5 pages https://doi.org/10.1155/2017/5924802 Research Article Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel
More informationPosition Statement on Management of the Axilla in Patients with Invasive Breast Cancer
- Official Statement - Position Statement on Management of the Axilla in Patients with Invasive Breast Cancer Sentinel lymph node (SLN) biopsy has replaced axillary lymph node dissection (ALND) for the
More informationThe GOSTT concept. (radio)guided intraoperative Scintigraphic Tumor Targeting. Emmanuel Deshayes. GOSTT = Radioguided Surgery
IAEA WorkShop, November 2017 Emmanuel Deshayes With the kind help of Pr Francesco Giammarile The GOSTT concept GOSTT = Radioguided Surgery (radio)guided intraoperative Scintigraphic Tumor Targeting 1 Radioguided
More informationSentinel node biopsy in breast cancer using infrared laser system first experience with PDE camera
reports of practical oncology and radiotherapy 1 6 (2 0 1 1) 82 86 available at www.sciencedirect.com journal homepage: http://www.rpor.eu/ Original article Sentinel node biopsy in breast cancer using
More informationBio-Optical Devices in Indocyanine Green Fluorescence Guided Sentinel Node Biopsy for Breast Cancer
78 The Open Surgical Oncology Journal, 2010, 2, 78-82 Open Access Bio-Optical Devices in Indocyanine Green Fluorescence Guided Sentinel Node Biopsy for Breast Cancer Toshiyuki Kitai *,1, Masahiro Kawashima
More informationDRAINAGE PATTERN OF THE UPPER MEDIAL QUADRANT OF THE BREAST IN YOUNG HEALTHY WOMEN AFTER SUBDERMAL INJECTION: A LYMPHSCINTIGRAPHIC STUDY
197 Lymphology 38 (2005) 197-201 DRAINAGE PATTERN OF THE UPPER MEDIAL QUADRANT OF THE BREAST IN YOUNG HEALTHY WOMEN AFTER SUBDERMAL INJECTION: A LYMPHSCINTIGRAPHIC STUDY A. Tassenoy, P. van der Veen, P.
More informationSentinel Lymph Node Biopsy Is Valuable For All Cancer. Surgery Grand Rounds Debate October 6, 2008 Joel Baumgartner
Sentinel Lymph Node Biopsy Is Valuable For All Cancer Surgery Grand Rounds Debate October 6, 2008 Joel Baumgartner History Lymphatics first described by Rasmus Bartholin in 1653 Rudolf Virchow postulated
More information2007 ICL SHANGHAI 24/03/2013
Background Intradermal Lymphoscintigraphy: Technical Improvement and an Interpretation of the Pathological Patterns on Clinical Management of Severe Stage Lymphoedema. Girolamo Tartaglione, MD Department
More informationWhat you should know about Sentinel Lymph Node Biopsy
What you should know about Sentinel Lymph Node Biopsy AFFILIATED WITH GENESIS MEDICAL CENTER 1228 East Rusholme Street, Suite 210 Davenport, Iowa 52803 (563) 421-7625 1-800-215-1444 www.genesishealth.com
More informationUse of the dye guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
456 Use of the dye guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection TOMOKO TAKAMARU 1, GORO KUTOMI 1, FUKINO SATOMI 1, HIROAKI
More informationBreast Reconstruction Postmastectomy. Using DermaMatrix Acellular Dermis in breast reconstruction with tissue expander.
Breast Reconstruction Postmastectomy. Using DermaMatrix Acellular Dermis in breast reconstruction with tissue expander. Strong and flexible Bacterially inactivated Provides implant support Breast Reconstruction
More informationMolecular Imaging and Breast Cancer
Molecular Imaging and Breast Cancer Breast cancer forms in tissues of the breast usually in the ducts, tubes that carry milk to the nipple, and lobules, the glands that make milk. It occurs in both men
More informationSENTINEL LYMPH NODE BIOPSY IN ORAL CAVITY SQUAMOUS CELL CARCINOMA WITHOUT CLINICALLY EVIDENT METASTASIS
SENTINEL LYMPH NODE BIOPSY IN ORAL CAVITY SQUAMOUS CELL CARCINOMA WITHOUT CLINICALLY EVIDENT METASTASIS Risto Kontio, MD, 1 I. Leivo, MD, PhD, 2 E. Leppänen, MD, 3 T. Atula, MD, PhD 4 1 Department of Maxillofacial
More informationMelanoma Surgery Update James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division
Melanoma Surgery Update 2018 James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division Surgery for Melanoma Mainstay of treatment for potentially
More informationEight false negative sentinel node procedures in breast cancer: what went wrong?
EJSO 2003; 29: 336±340 doi:10.1053/ejso.2002.1379 Eight false negative sentinel node procedures in breast cancer: what went wrong? S. H. Estourgie*, O. E. Nieweg*, R. A. ValdeÂs Olmos², E. J. Th. Rutgers*,
More informationNegative axillary sentinel node (SN) biopsy (SNB) Improved Sentinel Node Identification by SPECT/CT in Overweight Patients with Breast Cancer
Improved Sentinel Node Identification by SPECT/CT in Overweight Patients with Breast Cancer Hedva Lerman 1, Gennady Lievshitz 1, Osnat Zak 2, Ur Metser 1,3, Shlomo Schneebaum 3,4, and Einat Even-Sapir
More informationLymphoscintigraphy of the Upper Extremities
Lymphoscintigraphy of the Upper Extremities MJ de Haas, Meander Medical Centre Amersfoort (Retired) 1. Introduction Lymphoedema is a chronic, progressive, and often debilitating condition. Primary lymphoedema
More information16/09/2015. ACOSOG Z011 changing practice. Presentation outline. Nodal mets #1 prognostic tool. Less surgery no change in oncologic outcomes
ACOSOG Z011 changing practice The end of axillary US/FNA? Preoperative staging of the axilla in the era of Z011 Adena S Scheer MD MSc FRCSC Surgical Oncologist, St. Michael s Hospital Assistant Professor,
More informationT he purpose of axillary node dissection in breast cancer
546 ORIGINAL ARTICLE Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid N Lamichhane, K W Shen, C L Li, Q X Han, Y J Zhang, Z M Shao, Z Z Shen...
More informationHow To Make a Good Mastectomy for Reconstruction Based on the Anatomy. Zhang Jin, Ph.D MD
How To Make a Good Mastectomy for Reconstruction Based on the Anatomy Zhang Jin, Ph.D MD Deputy Director and Professor Tianjin Medical University Cancer Institute and Hospital People s Republic of China
More informationCutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)
The Sentinel Node in Head and Neck Melanoma Cutaneous Melanoma: Epidemiology (USA) 6 th leading cause of cancer among men and women 68,720 new cases of invasive melanoma in 2009 8,650 deaths from melanoma
More informationUvA-DARE (Digital Academic Repository)
UvA-DARE (Digital Academic Repository) In search of the sentinel node : validation and sophistication of lymphatic mapping and sentinel node biopsy in breast cancer and melanoma van der Ploeg, I.M.C. Link
More informationMitchell Buller, MEng, a Adee Heiman, BA, a Jared Davis, MD, b ThomasJ.Lee,MD, b Nicolás Ajkay, MD, FACS, c and Bradon J. Wilhelmi, MD, FACS b
Immediate Breast Reconstruction of a Nipple Areolar Lumpectomy Defect With the L-Flap Skin Paddle Breast Reduction Design and Contralateral Reduction Mammoplasty Symmetry Procedure: Optimizing the Oncoplastic
More information«Aut tace aut loquere meliora silentio» Francesco GIAMMARILE
«Aut tace aut loquere meliora silentio» Francesco GIAMMARILE Presentation Outline Introduction: the GOSTT Concept The EANM Guideline in Melanoma Future trends and concluding remarks I sort of thought your
More informationDespite breast reduction being one of the BREAST. Does Knowledge of the Initial Technique Affect Outcomes after Repeated Breast Reduction?
BREAST Does Knowledge of the Initial Technique Affect Outcomes after Repeated Breast Reduction? Jamil Ahmad, M.D. Sarah M. McIsaac, M.D. Frank Lista, M.D. Mississauga and Ottawa, Ontario, Canada Background:
More informationSENTINEL LYMPH NODE CONCEPT IN OESOPHAGEAL CANCER
SENTINEL LYMPH NODE CONCEPT IN OESOPHAGEAL CANCER Sarah K Thompson, M.D. Queenstown ANZGOSA Mtg, 2010 Sentinel Lymph Node (SLN) Sentinel Lymph Node (SLN) Not always on a direct drainage pathway Not always
More informationAxillary Reverse Mapping to Reduce the Incidence of Lymphedema
Axillary Reverse Mapping to Reduce the Incidence of Lymphedema Nathalie Johnson,MD,FACS Medical Director, Legacy Cancer Institute and Breast Health Centers Portland,Oregon Objectives for Learning Understand
More informationCASE REPORT Blocking of the Lymphatic Vessel in Lymphedema
CASE REPORT Blocking of the Lymphatic Vessel in Lymphedema Hisako Hara, MD, and Makoto Mihara, MD Department of Lymphatic and Reconstructive Surgery, Saiseikai Kawaguchi General Hospital, Saitama, Japan
More informationThe Study of 99m Tc-Aluminum Oxide Using for Sentinel Lymph Nodes Detection in Experiment
IOP Conference Series: Materials Science and Engineering PAPER OPEN ACCESS The Study of Tc-Aluminum Oxide Using for Sentinel Lymph Nodes Detection in Experiment To cite this article: A.A. Medvedeva et
More informationCHARACTERIZATION OF CONGENITAL VASCULAR MALFORMATION IN THE EXTREMITIES USING WHOLE BODY BLOOD POOL SCINTIGRAPHY AND LYMPHSCINTIGRAPHY
77 Lymphology 42 (2009) 77-84 CHARACTERIZATION OF CONGENITAL VASCULAR MALFORMATION IN THE EXTREMITIES USING WHOLE BODY BLOOD POOL SCINTIGRAPHY AND LYMPHSCINTIGRAPHY Y.H. Kim, J.Y. Choi, Y.W. Kim, D.I.
More informationNonvisualization of sentinel node by lymphoscintigraphy in advanced breast cancer
Radiology Case Reports Nonvisualization of sentinel node by lymphoscintigraphy in advanced breast cancer Volume 5, Issue 3, 2010 Brian Wosnitzer, MD; Rosna Mirtcheva, MD; and Munir Ghesani, MD Previous
More informationThe Use of Vertical Scar Techniques in Reconstructive Surgery
The Use of Vertical Scar Techniques in Reconstructive Surgery 12 Moustapha Hamdi, Phillip Blondeel, Koenraad Van Landuyt, Stan Monstrey H e who does not possess a thing cannot give it. Folk tradition Introduction
More informationDiagnosis and staging of breast cancer and multidisciplinary team working
1 Diagnosis and staging of breast cancer and multidisciplinary team working Common symptoms and signs Over 90% of breast cancers (BCs) are local or regional when first detected. At least 60% of patients
More informationVascularized Lymph Node Transfer From Thoracodorsal Axis for Congenital and Post Filarial Lymphedema of the Lower Limb
CASE REPORT Vascularized Lymph Node Transfer From Thoracodorsal Axis for Congenital and Post Filarial Lymphedema of the Lower Limb HARI VENKATRAMANI, MCh, DNB, EDHS,* SENTHIL KUMARAN, MCh, SHIVANNAIAH
More informationRELATIONSHIP BETWEEN LYMPHOSCINTIGRAPHY AND CLINICAL FINDINGS IN LOWER LIMB LYMPHEDEMA (LO): TOWARD A COMPREHENSIVE STAGING
1 Lymphology 41 (2008) 1-10 RELATIONSHIP BETWEEN LYMPHOSCINTIGRAPHY AND CLINICAL FINDINGS IN LOWER LIMB LYMPHEDEMA (LO): TOWARD A COMPREHENSIVE STAGING A.P. Pecking, J.L. Albérini, M. Wartski, V. Edeline,
More informationBreast Cancer. What is breast cancer?
Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps
More informationCanadian Scientific Journal. Intraoperative color detection of lymph nodes metastases in thyroid cancer
Canadian Scientific Journal 2 (2014) Contents lists available at Canadian Scientific Journal Canadian Scientific Journal journal homepage: Intraoperative color detection of lymph nodes metastases in thyroid
More informationSentinel lymph node (SLN) biopsy is a wellestablished
ORIGINAL ARTICLE DISCORDANT LYMPHATIC DRAINAGE PATTERNS REVEALED BY SERIAL LYMPHOSCINTIGRAPHY IN CUTANEOUS HEAD AND NECK MALIGNANCIES Alliric I. Willis, MD, John A. Ridge, MD, PhD Department of Surgical
More informationUvA-DARE (Digital Academic Repository)
UvA-DARE (Digital Academic Repository) In search of the sentinel node : validation and sophistication of lymphatic mapping and sentinel node biopsy in breast cancer and melanoma van der Ploeg, I.M.C. Link
More informationIs early dynamic lymphoscintigraphy for detection of sentinel lymph nodes always achievable in breast tumor?
ORIGINAL ARTICLE Annals of Nuclear Medicine Vol. 20, No. 1, 45 50, 2006 Is early dynamic lymphoscintigraphy for detection of sentinel lymph nodes always achievable in breast tumor? Yu-Wen CHEN,* Ya-Wen
More informationRemoval of sentinel lymph node(s)
Removal of sentinel lymph node(s) Exceptional healthcare, personally delivered What is a sentinel lymph node? The sentinel lymph nodes (glands) are the first lymph nodes in your armpit to which breast
More informationComparison of intra-operative gamma probe detection with postoperative SPECT/CT of sentinel nodes related to the ovary.
Journal of Nuclear Medicine, published on October 13, 2016 as doi:10.2967/jnumed.116.183426 Comparison of intra-operative gamma probe detection with postoperative SPECT/CT of sentinel nodes related to
More informationContributo della medicina nucleare nei tumori mammari: dal linfonodo sentinella alla IART
Contributo della medicina nucleare nei tumori mammari: dal linfonodo sentinella alla IART Prof. Giovanni Paganelli Dipartimento delle procedure e tecnologie avanzate, IRST-IRCCS Meldola. Universita degli
More informationPeter Ell 2000 [1] 1977 Cabanas [2]
1,2 3 3 1 2 3 Peter Ell 2000 [1] 1977 Cabanas [2] (vital blue) [3] [4] Table 1 2002;15:43-48 (Table 2) Table 1. Successful rates of sentinel node identification [34] 90 9 6 90 11 19 90 12 4 114 325 (02)-87927374
More informationScintimammography and Gamma Imaging of the Breast and Axilla
Scintimammography and Gamma Imaging of the Breast and Axilla Policy Number: 6.01.18 Last Review: 9/2017 Origination: 9/2006 Next Review: 9/2018 Policy Blue Cross and Blue Shield of Kansas City (Blue KC)
More informationBreast Cancer. What is breast cancer?
Scan for mobile link. Breast Cancer Breast cancer is a malignant tumor in or around breast tissue. It usually begins as a lump or calcium deposit that develops from abnormal cell growth. Most breast lumps
More informationInvestigation of lymphatic edema requires a reliable
Quantification of Lymphatic Function for Investigation of Lymphedema: Depot Clearance and Rate of Appearance of Soluble Macromolecules in Blood Simon J. Pain, MA 1 ; R. Steven Nicholas, PhD 2 ; Robert
More informationSurgery Choices for Breast Cancer
Surgery Choices for Breast Cancer Surgery Choices for Women with DCIS or Breast Cancer As a woman with DCIS (ductal carcinoma in situ) or breast cancer that can be removed with surgery, you may be able
More informationLymphoscintigraphy in the Sentinel Lymph Node Technique for Breast Tumor: Value of Early and Late Images for the Learning Curve
Original Paper Med Princ Pract 2003;12:17 22 DOI: 10.1159/000068161 Received: April 2, 2002 Revised: August 3, 2002 Lymphoscintigraphy in the Sentinel Lymph Node Technique for Breast Tumor: Value of Early
More informationWhat Is a Sentinel Node? Re-Evaluating the 10% Rule for Sentinel Lymph Node Biopsy in Melanoma
Journal of Surgical Oncology 2007;95:623 628 What Is a Sentinel Node? Re-Evaluating the 10% Rule for Sentinel Lymph Node Biopsy in Melanoma HIDDE M. KROON, MD, 1 LORI LOWE, MD, 2 SANDRA WONG, MD, 1 DOUG
More informationM D..,., M. M P.. P H., H, F. F A.. A C..S..
Implications of NSABP B-32 and Loco-Regional Therapy Considerations After Neoadjuvant Chemotherapy Terry Mamounas, M.D., M.P.H, F.A.C.S. Professor of Surgery Northeastern Ohio Medical University Medical
More informationORIGINAL ARTICLE. (SLN) biopsy is revolutionizing
ORIGINAL ARTICLE Management of Malignant Melanoma of the Head and Neck Using Dynamic Lymphoscintigraphy and Gamma Probe Guided Sentinel Lymph Node Biopsy Grant W. Carlson, MD; Douglas R. Murray, MD; Robert
More informationOncoplastic breast surgery in a Danish perspective II: Reconstructive strategy in oncoplastic breast surgery
Oncoplastic breast surgery in a Danish perspective II: Reconstructive strategy in oncoplastic breast surgery Michael Rose, MD Department of Surgery and Plastic Surgery, Hospital of Southwest Jutland, Denmark
More informationRole of positron emission mammography (PEM) for assessment of axillary lymph node status in patients with breast cancer
Role of positron emission mammography (PEM) for assessment of axillary lymph node status in patients with breast cancer Poster No.: C-1260 Congress: ECR 2011 Type: Scientific Paper Authors: K. M. Kulkarni,
More informationPercutaneous Biopsy and Sentinel Lymphadenectomy: Minimally Invasive. he diagnosis and treatment of nonpalpable. Breast Cancer
Laura Liberman 1 Hiram S. Cody III 2 Received January 30, 2001; accepted after revision April 3, 2001. Supported by a grant from the New York State Department of Health (C015709). 1 Department of Radiology,
More informationBreast Cancer Surgery Options
YOUR VALUES YOUR PREFERENCES YOUR CHOICE Breast Cancer Surgery Options Lumpectomy With Radiation Therapy or Mastectomy Members of Your Health Care Team Breast surgeon A breast surgeon will talk with you
More informationONCOPLASTIC SURGERY. Dr. Sadir Alrawi Director of Surgical Oncology Services. Dr. Humaa Darr Surgical Oncology Fellow
Hessa St ONCOPLASTIC SURGERY Dr. Sadir Alrawi Director of Surgical Oncology Services Dr. Humaa Darr Surgical Oncology Fellow Al Sufouh Rd AL SUFOUH AL SUFOUH Sharaf DG Mall of the Emirates Mall Of the
More informationEvolution of Breast Surgery
Evolution of Breast Surgery Natasha Rueth MD Surgical Oncologist Piper Breast Center and Alina Health Surgical Specialists Minneapolis, MN Definitions Radical Mastectomy: Removal of breast, chest muscles,
More informationOncoplastic Breast Surgery
Disclosures Oncoplastic Breast Surgery Newfoundlander OAGS 2016 Dr Renee Hanrahan General Surgeon Oncologic and Reconstructive Breast Surgeon Objectives What is Oncoplastic Surgery Define Oncoplastic Surgery
More informationversion 1.0, approved June 15, 2002 I. Purpose Background Information and Definitions
Society of Nuclear Medicine Procedure Guideline for Lymphoscintigraphy and the Use of Intraoperative Gamma Probe for Sentinel Lymph Node Localization in Melanoma of Intermediate Thickness version 1.0,
More informationSurgery for Breast Cancer
Surgery for Breast Cancer 1750 Mastectomy - Petit 1894 Radical mastectomy Halsted Extended, Super radical mastectomy 1948 Modified radical mastectomy Patey 1950-60 WLE & RT Baclesse, Mustakallio 1981-85
More informationUpdate on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact
Update on Sentinel Node Biopsy in Endometrial Cancer: Feasibility, Technique, Impact Bjørn Hagen, MD, PhD St Olavs Hospital Trondheim University Hospital Trondheim, Norway Endometrial Cancer (EC) The most
More informationModified Radical Mastectomy
Modified Radical Mastectomy Valerie L. Staradub, MD, and Monica Morrow, MD S urgical management options for breast cancer include modified radical mastectomy (MRM), MRM with immediate reconstruction, and
More informationI. Cancer staging problem
Instrumentation Lab (Craig Levin) Angela Craig Peter Jin Frezghi Guillem Billie Garry Research interests (by imaging modality) I. High resolution radionuclide imaging : positron emission tomography (PET)
More informationCASE REPORT An Innovative Solution to Complex Inguinal Defect: Deepithelialized SIEA Flap With Mini Abdominoplasty
CASE REPORT An Innovative Solution to Complex Inguinal Defect: Deepithelialized SIEA Flap With Mini Abdominoplasty Augustine Reid Wilson, MS, Justin Daggett, MD, Michael Harrington, MD, MPH, and Deniz
More informationRadiopharmacy. Prof. Dr. Çetin ÖNSEL. CTF Nükleer Tıp Anabilim Dalı
Prof. Dr. Çetin ÖNSEL CTF Nükleer Tıp Anabilim Dalı What is Nuclear Medicine? Nuclear Medicine is the branch of medicine concerned with the use of radionuclides in the study and the diagnosis of diseases.
More informationBreast cancer: an update
Breast cancer: an update Dr. Sanjeewa Seneviratne M.D, MRCS, Ph.D. Senior Lecturer and Honorary Consultant Surgeon Department of Surgery Faculty of Medicine, Colombo Plan The problem Screening & early
More informationIntegrating new imaging modalities in breast cancer management Pouw, Bas
UvA-DARE (Digital Academic Repository) Integrating new imaging modalities in breast cancer management Pouw, Bas Link to publication Citation for published version (APA): Pouw, B. (2016). Integrating new
More informationMamma Centrum / Zelený Pruh - Prague, Czech Republic
- Prague, Czech Republic General Information New breast cancer cases treated per year 490 Breast multidisciplinarity team members 29 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationJPRAS Open 3 (2015) 1e5. Contents lists available at ScienceDirect. JPRAS Open. journal homepage:
JPRAS Open 3 (2015) 1e5 Contents lists available at ScienceDirect JPRAS Open journal homepage: http://www.journals.elsevier.com/ jpras-open Case report The pedicled transverse partial latissimus dorsi
More informationBreast Cancer: Management of the Axilla in Greg McKinnon MD FRCSC SON Vancouver Oct 2016
Breast Cancer: Management of the Axilla in 2016 Greg McKinnon MD FRCSC SON Vancouver Oct 2016 No Disclosures Principle #1 There is no point talking about surgical therapy in isolation. From a patient
More informationCOPE Library Sample
Breast Anatomy LOBULE LOBE ACINI (MILK PRODUCING UNITS) NIPPLE AREOLA COMPLEX ENLARGEMENT OF DUCT AND LOBE LOBULE SUPRACLAVICULAR NODES INFRACLAVICULAR NODES DUCT DUCT ACINI (MILK PRODUCING UNITS) 8420
More informationBreast Clinica de la Mama and Italian Hospital - La Plata, Argentina
- La Plata, Argentina General Information New breast cancer cases treated per year 382 Breast multidisciplinarity team members 18 Radiologists, surgeons, pathologists, medical oncologists, radiotherapists
More informationMehmet Eser 1, Metin Kement 1,4*, Levent Kaptanoglu 1, Melin Gecer 2, Evrim Abamor 3, Firat Tutal 1, Salim Balin 1, Necmi Kurt 1 and Huseyin Uzun 1
Eser et al. BMC Surgery 2013, 13:13 RESEARCH ARTICLE Open Access A prospective comparative study to assess the contribution of radioisotope tracer method to dye-only method in the detection of sentinel
More informationRecurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction
Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Aldona J. Spiegel, M.D., and Charles E. Butler, M.D. Houston, Texas Skin-sparing
More information1
www.clinicaloncology.com.ua 1 Prognostic factors of appearing micrometastases in sentinel lymph nodes in skin melanoma M.N.Kukushkina, S.I.Korovin, O.I.Solodyannikova, G.G.Sukach, A.Yu.Palivets, A.N.Potorocha,
More information